功能与经更年期骨质疏松症妇女骨矿物质密度的变化有关,这些妇女接受了丹诺苏马布治疗:来自回顾性队列研究的数据
Antonino Catalano1, Cecilia Oliveri1, Giuseppe Natale2
1Unit and School of Geriatrics, Department of Clinical and Experimental Medicine, University of Messina, Policlinico "G. Martino", 98124 Messina, Italy.
Journal of clinical medicine
|October 26, 2024
概括
通过估计的膜过率 (eGFR) 测量功能,影响了登索马布在患有骨质疏松症的绝经后妇女中改善骨矿物密度 (BMD) 的程度. 较低的eGFR与更大的BMD增长有关,这表明个性化治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 骨质疏松症研究 骨质疏松症研究
背景情况:
- 功能对骨代谢至关重要;功能衰竭会增加骨折的风险.
- 德诺苏马布是一种成熟的骨质疏松症治疗方法,但其与功能相对的有效性需要实践调查.
研究的目的:
- 评估功能对德诺苏马布改善骨矿物质密度 (BMD) 的疗效的影响.
- 在绝经后的妇女中,分析代诺苏马布诱导的BMD变化在不同的估计质过率 (eGFR) 类别中.
主要方法:
- 对接受德诺苏马布 (60毫克每6个月) 的绝经后妇女的回顾性分析.
- 使用2021年CKD-EPI方程评估估计的淋巴球过率 (eGFR) 的功能.
- 通过双能X射线吸收计 (DXA) 测量骨矿物质密度 (BMD).
主要成果:
- 所有128名参与者均在平均治疗时间3.9年后显示出改善的BMD.
- 较低的eGFR独立地与较大的腰椎骨质量增加有关 (p=0.01).
- 年龄和eGFR与大腿部骨质量变化相关 (分别为p=0.03和p=0.04).
结论:
- 估计的淋巴膜过率 (eGFR) 与德诺苏马布在增强骨质量方面的有效性有显著关联.
- 研究结果表明,在评估绝经后骨质疏松症中登苏马布治疗结果时,应该考虑功能.
相关概念视频
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
01:40Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
01:25Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
01:11Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
01:17Factors Affecting Renal Clearance: Renal Impairment
58
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
58